Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
People who are obese (have a BMI greater than or equal to 30) are clinically eligible for GLP-1 drugs, but employer plans may set additional BMI requirements to cover GLP-1 drug use under obesity
Invert the vial so the needle tip is submerged in liquid
Avoiding Bruising or Irritation Rotate sites : Regularly change your injection location to prevent irritation and ensure even absorption
Partnering with an experienced CDMO like Bachem can help navigate these considerations efficiently, leveraging established peptide synthesis platforms and large-scale capabilities
Robert Steinbrook, director of the Public Citizen Health Research Group, terms GLP-1 agonists for weight loss a real-time experiment with unknown long-term risks
US$ 28.23
US$ 22.12
US$ 23.30
US$ 23.73
US$ 26.56
